Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
NCT ID:
NCT00270166
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of multiple myeloma, lymphoma, breast cancer, ovarian cancer, small-cell lung cancer, esophagus cancer, or prostate cancer
* receiving treatment with chemotherapy, with at least 3 additional months of chemotherapy planned
* a self-care performance score of 0 (fully active, no disease restriction) to 3 (capable of only limited self-care, confined to bed or chair more than 50% of waking hours)
* life expectancy of at least 6 months
* baseline hemoglobin \<12 grams per deciliter and baseline count of \<100,000 microliter for developing red cells
Exclusion Criteria:
* Clinically significant disease other than cancer
* evidence of uncontrolled hypertension or history of seizure
* transfusion within 1 week of the study
* radiotherapy within 2 weeks of study start
* use of corticosteroid or steroid drugs during the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00270166
Study Brief:
Protocol Section:
NCT00270166